Cost Analysis of Integrative Inpatient Treatment Based on DRG Data: The Example of Anthroposophic Medicine

Table 3

Structural and cost data distribution in cases with/without anthroposophic medical complex (AMC) treatment.

	Without AMC	With AMC
Cases
Hospital 1	10,617 (97.4%)	273 (2.6%)
Hospital 2	9,405 (92.6%)	697 (7.4%)
Hospital 3	1,827 (80.2%)	361 (19.8%)
Total	21,849 (93.9%)	1,331 (6.1%)
Average length of stay
All (SD)	6.1 (5.2)	19.5 (14.9)
Inlier (SD)	6.2 (4.9)	14.7 (7.9)
German InEK catalog	6.2	10.9
% under average length of stay
All	55.7%	5.9%
Inlier	50.7%	10.6%
% cases
Low outlier	15.1%	0.1%
Inlier	76.0%	53.1%
High outlier	6.8%	46.6%
Transferred^3	2.0%	0.2%
Remuneration of all cases in €
DRG income^1 (sd)	2,473 (2,864)	6,405 (12,619)
ZE income^2 (sd)	66 (417)	111 (635)
Total income (sd)	2,540 (2,956)	6,516 (12,835)
Remuneration inlier in €
DRG income^1 (sd)	2,650 (2,779)	5,863 (11,109)
ZE income^2 (sd)	57 (392)	86 (606)
Total income (sd)	2,707 (2,865)	5,949 (11,344)
Cost in €
Cost (all) (sd)	2,417 (3,145)	7,992 (11,019)
Cost (inlier) (sd)	2,451 (3,037)	6,724 (9,323)
Cost (inlier)/ZE income	2,394	6,638
Cost (InEK)	2,387	5,244

¹DRG income: revenues through lump compensation.
²ZE income: revenues through additional remuneration.
³Cases transferred to or transferred from other hospitals with length of stay shorter than the average of the respective DRG (and therefore subject to deductions).